86 results
POS AM
PPBT
Purple Biotech Ltd
28 Mar 24
Prospectus update (post-effective amendment)
4:01pm
was obtained by fraud;
the opportunity given to the defendant to bring its arguments and evidence before the court was not reasonable in the opinion
424B3
PPBT
Purple Biotech Ltd
14 Nov 23
Prospectus supplement
4:13pm
by fraud;
the opportunity given to the defendant to bring its arguments and evidence before the court was not reasonable in the opinion of the Israeli
F-1/A
oj2orw
13 Nov 23
Registration statement (foreign) (amended)
4:11pm
D
fco w6018
31 Oct 23
$5.43 mm in options / securities to be acquired, sold $5.43 mm, 1 investor
4:30pm
F-1
rcb3e
30 Oct 23
Registration statement (foreign)
4:30pm
6-K
EX-4.1
j1bxf9l
19 Oct 23
Report of Foreign Private Issuer
10:36am
424B5
wff wbkka3jh6h
19 Oct 23
Prospectus supplement for primary offering
10:27am
F-3/A
n2dow0pe7vrq
17 May 23
Shelf registration (foreign) (amended)
5:20pm
424B3
28vw eh4p
5 Apr 23
Prospectus supplement
5:21pm
424B3
l20hy35aqs 6x
3 Apr 23
Prospectus supplement
8:57am
F-3
qi6 n3fgo8m0i3
7 Dec 22
Shelf registration (foreign)
9:17pm
6-K
EX-1.1
3lwovej6pur3fzhj
9 Jun 21
Report of Foreign Private Issuer
5:06pm
424B5
m650a5ret1 m6j6ws
9 Jun 21
Prospectus supplement for primary offering
4:54pm